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ABSTRACT: Human norovirus (NoV) remains the most common cause of viral gastroenteritis and the leading cause of viral 
foodborne outbreaks globally. NoV is highly pathogenic with an estimated median viral infective dose (ID50) ranging from 
18 to 1,015 genome copies. For NoV detection, the only reliable and sensitive method available for detection and 
quantification is RTqPCR. NoV detection in food is particularly challenging, requiring matrix specific concentration of the 
virus and removal of inhibitory compounds to detection assays. Hence, the RTqPCR method poses some challenges for rapid 
in-field or point-of-care diagnostic applications. We propose a new colorimetric NanoZyme aptasensor strategy for rapid 
(10 min) and ultrasensitive (calculated LoD of 3 viruses per assay equivalent to 30 viruses/mL of sample and 
experimentally-demonstrated LoD of 20 viruses per assay equivalent to 200 viruses/mL) detection of the infective murine 
norovirus (MNV), a readily-cultivable surrogate for NoV. Our approach combines the enzyme-mimic catalytic activity of gold 
nanoparticles with high target specificity of an MNV aptamer to create sensor probes that produce a blue colour in the 
presence of this norovirus, such that the colour intensity provides the virus concentrations. Overall, our strategy offers the 
most sensitive detection of norovirus or a norovirus surrogate achieved to date using a biosensor approach, enabling for the 
first time, the detection of MNV virion corresponding to the lower end of the ID50 for NoV. We further demonstrate the 
robustness of the norovirus NanoZyme aptasensor by testing its performance in the presence of other non-target 
microorganisms, human serum and shellfish homogenate, supporting the potential of detecting norovirus in complex 
matrices. This new assay format can, therefore, be of significant importance as it allows ultrasensitive norovirus detection 
rapidly within minutes, while also offering the simplicity of use and need for non-specialized laboratory infrastructure.
Norovirus (NoV) belongs to a genetically diverse group of 
small, icosahedral, non-enveloped viruses with a positive 
sense single-stranded RNA (ssRNA) genome.1-2 They are 
the members of the family Caliciviridae and are the major 
cause of acute viral gastroenteritis worldwide, commonly 
known as “winter vomiting disease”.1-2 NoV is highly 
contagious due to its low infective dose (median infective 
dose, ID50 estimated at 18 to 1,015 genome copies),3 
prolonged period of viral shedding, asymptomatic 
infection in some individuals, high reoccurrence rate and 
high stability within the environment; posing major 
challenges in NoV management.1 NoV is primarily spread 
through person-to-person contact, as well as, through 
consumption of contaminated food or water, aerosolised 
vomit particles or contact with contaminated surfaces. NoV 
is estimated to account for 267 million infections and over 
200,000 deaths (particularly in the young, elderly and 
immunosuppressed patients) per year,4-5 with outbreaks 
often occurring in semi-closed communities such as 
schools, nursing homes, hospitals and cruise ships.6 Foods 
can become contaminated via contact with contaminated 
water, poor hygiene and food handlers, with foods of 
highest risk being raw shellfish, berries and ready-to-eat 
foods. Furthermore, the open cross-border trade policies 
of food products promote global outbreaks.7-10 Collectively, 
these highlight the need for a rapid and accurate detection 
strategy for this important human and foodborne 
pathogen. 
The current gold standard for NoV detection and 
quantification is based on gene amplification techniques 
such as reverse transcription quantitative polymerase 
chain reaction (RTqPCR),4-5 although a number of 
alternative methods for NoV detection have been reported 
(Table 1).1-2, 7, 11 To our knowledge, the most sensitive 
alternative NoV detection system reported till date is 
based on an electrochemical aptasensor approach, wherein 
the binding of 
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Scheme 1. Working principle of the norovirus NanoZyme aptasensor. Schematic illustration outlining the steps involved 
during norovirus sensing. Step 1 shows the NanoZyme activity of GNPs that converts a colourless TMB substrate to a blue oxidized 
product. Step 2 involves the non-covalent adsorption of the MNV-specific AG3 aptamer molecules on to the surface of GNPs leading 
to the loss of the inherent NanoZyme activity. This GNP-aptamer conjugate serves as the ‘Sensor Probe’. Step 3 involves the 
incubation of the sensor probe with different cells, including murine norovirus (specific target), MS2 phage (structurally similar to 
norovirus), S. aureus and E. coli. Step 4 shows that in the presence of norovirus, the aptamers desorb from the surface of the GNPs 
leading to the recovery of the NanoZyme activity, producing a blue colour. The intensity of colour will be proportional to the 
amount of norovirus present in the sample. In contrast, since aptamers will not have any affinity to other contaminants, no 
recovery of the NanoZyme activity will be observed, thereby resulting in no colour in the presence of non-specific targets. 
norovirus to highly specific DNA aptamers afforded a 
calculated limit of detection (LoD) of 180 murine 
norovirus (MNV) particles or 6,000 MNV/mL.2 While 
promising, this LoD is still far-off from meeting the lower 
end of the median viral infective dose (ID50), estimated to 
range from 18 to 1,015 genome copies.3 Development of an 
ultrasensitive, specific, rapid and user-friendly platform 
for NoV detection would be particularly advantageous for 
detecting clinical, environmental and food contamination, 
with a possibility of portable in-field translation.
The developments in nanotechnology have seen the 
emergence of colorimetric and other potential biosensing 
platforms as a viable technology for point-of-care 
devices.12-27 Gold nanoparticles (GNPs), in particular, have 
been at the forefront due to well-established synthesis 
routes, ease of surface functionalisation, high stability, low 
cost, low toxicity and remarkable surface plasmon 
resonance (SPR) properties that allow a visual read-out of 
the sensing event.28-38 However, GNP-based sensors that 
rely on colour generation via the SPR properties of gold 
find it rather challenging to avoid aggregation in complex 
biological fluids, resulting in non-specificity and false 
positives.39-42 In recent years, the aggregation-induced 
non-specificity of GNPs has been overcome by developing 
GNP-based NanoZyme sensors that do not rely upon the 
SPR properties, but instead take advantage of the enzyme-
mimicking catalytic activity of gold to convert a colourless 
substrate into a coloured product.43-48 However, in the 
absence of a targeting moiety, the applicability of 
NanoZyme sensors remains limited, as NanoZymes can 
exhibit broad-spectrum catalytic activities against a range 
of substrates. More recently, we have been able to add an 
element of specificity in NanoZyme sensors by 
incorporating target-specific molecular recognition 
elements (MREs) to allow colorimetric detection of small 
molecules such as pesticides and antibiotics.49-50 
The use of MREs is common in traditional biomolecular 
detection systems, e.g., antibodies as in enzyme-linked 
immunosorbent assay (ELISA),51 unique polynucleotide 
sequences in PCR,52 or lectins in lectin-binding assays 
(LBA).53 A relatively new class of non-stereotypical MRE 
that has remarkable potential in providing specificity to 
biosensors are aptamers.16, 54 These synthetic nucleic acids 
fold into unique three-dimensional conformations and are 
capable of binding to their targets with high specificity and 
outstanding affinity.16, 55 The distinguishing feature of 
aptamers from other MREs is that they can be raised in 
silico against the vast majority of targets ranging from 
small molecules49-50 to complex biological entities such as 
cancer cells,56-57 pathogenic bacteria58-59 and viruses.2, 60 
Aptamers are particularly attractive for biosensors 
development as they also exhibit high ambient storage 
stability and affordable on-going in vitro synthesis cost 
once the aptamers have been designed for a particular 
assay.16, 55, 61
In the current study, we combine the outstanding target-
specificity of a MNV AG3 aptamer2 with the NanoZyme 
activity of GNPs to develop a rapid colorimetric sensor for 
ultrasensitive and highly specific detection of the MNV 
virion. The two reasons for using MNV instead of human 
norovirus (HuNoVs) are: (i) the production of HuNoV 
involves laborious process62 and (ii) murine NoV is an 
infectious easily cultivable human NoV surrogate enabling 
the infective particles to be accurately quantified using a 
plaque assay. Such a model allows the developed senor to 
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be evaluated for accuracy in detecting infective virus 
particles as opposed to non-infective coat protein or non- 

















Fig. 1. Sensor probe fabrication. Decrease in the NanoZyme 
activity of the GNPs plotted as a function of AG3 aptamer 
concentration. The data was fitted (red curve) using a non-
linear least square reverse Hill equation.
encapsidated/damaged viral genome. Neither VLP or NoV 
strains sourced from human faeces accurately allow for 
this as quantification is based on total protein 
concentration or detection of both infective and non-
infective viral genomes, respectively. Therefore, the 
current work utilises murine norovirus (MNV), a cultivable 
surrogate of NoV as a model system, and demonstrates 
that the proposed NanoZyme aptasensor technology can 
detect the infective MNV with a calculated LoD of just 3 
viruses in 100 µL sample (equivalent to 30 viruses/mL), 
the lowest known limit, achieved to date, and that too 
within a short assay time of only 10 min. We further 
demonstrate the potential applicability of our Nanozyme 
aptasensor in the real-world scenario by demonstrating 
that it retains its functionality in the presence of potential 
contaminants such as other bacteria and viruses, while 
being able to reliably detect MNV in complex matrices of 
human serum and shellfish homogenate. These outcomes 
offer new opportunities for practical deployment of the 
norovirus NanoZyme aptasensor for detecting human 
infections as well as contaminated food.
Scheme 1 illustrates the NanoZyme aptasensor approach 
for colorimetric detection of norovirus, providing an 
ultrasensitive and highly specific visual readout of the 
sensing event within 10 min. The underlying concept is 
built around utilising the inherent peroxidase-like 
NanoZyme activity of GNPs to generate a characteristic 
blue colour through the oxidation of a colourless 
peroxidase substrate TMB (3,3',5,5'-tetramethylbenzidine) 
(Step 1). Surface passivation of the GNPs with a MNV 
capsid-specific AG3 aptamer2 results in the loss of the 
colour-generating NanoZyme activity (Step 2). This GNP-
aptamer nanoconjugate serves as the sensor probe. When 
this sensor probe is exposed to the analyte (Step 3), the 
NanoZyme activity towards generating blue colour via 
TMB oxidation is selectively recovered in the presence of 
norovirus, and not in the presence of any other non-
specific virus or bacterial cell (Step 4). The recovery of the 
NanoZyme activity in the presence of norovirus is due to 
the high affinity of AG3 aptamer towards MNV, which 
causes conformational changes in the aptamer in the 
presence of norovirus, leading to their displacement from 
the GNP surface and binding to the MNV capsid. This 
aptamer desorption exposes the catalytic sites on the 
surface of the GNPs to allow TMB oxidation into a blue 
product. In contrast, in the absence of norovirus, but in the 
presence of non-specific targets such as Gram-positive 
bacteria Staphylococcus aureus, Gram-negative bacteria 
Escherichia coli, or even a structurally similar virus such as 
E. coli bacteriophage MS2 (MS2 phage), the aptamers do 
not desorb from the GNP surface and the NanoZyme 
activity is not recovered, thereby offering selectivity to the 
sensor. 
As the generation of blue colour due to the NanoZyme 
activity of the GNPs is central to the sensor mechanism, we 
first established the enzyme-like characteristics of 
tyrosine-functionalized GNPs (detailed in Supporting 
Information, Fig. S1–S4) synthesized using a previously 
established protocol (Fig. S1). The GNPs were of low 
polydispersity, high crystallinity, and of quasi-spherical 
morphology with an average diameter of ca. 20 nm (Fig. 
S2). The peroxidase-mimic NanoZyme activity of these 
GNPs shows nanoparticle, TMB and H2O2 concentration-
dependent increase in activity (Fig. S3), as observed for 
other NanoZymes.12, 45-46, 49-50, 63-64 We also calculated the 
kinetic parameters such as Michaelis-Menten constant 
(Km), maximum initial velocity (Vmax) and turnover 
number (Kcat) for the NanoZyme-driven reactions (Table 
S1 and Fig. S4). The NanoZyme kinetic parameters suggest 
that tyrosine-functionalized GNPs offer over three order of 
magnitude higher affinity to colorigenic TMB substrate in 
comparison to that to the co-substrate H2O2. This is a 
desirable property in terms of achieving high sensitivity 
and reproducibility during sensing, as high affinity of 
NanoZyme towards TMB is likely to allow even low 
concentrations of target analyte to be identified while 
using the sensor probe developed in the next stage.
We then developed the sensor probe through binding of 
MNV-specific AG3 aptamer to the surface of GNPs. This 
required determination of the minimum concentration of 
the AG3 aptamer needed to passivate the GNP surface 
without the availability of excessive amounts of free 
aptamer molecules around the GNP-aptamer 
nanoconjugates. Fig. 1 shows that the NanoZyme activity 
of GNPs decreases with the increasing aptamer 
concentration, as structural flexibility of aptamers allows 
them to passivate the GNP surface via electrostatic 
interactions.65 As such, our calculations reveal that an 
optimum sensor probe requires an average of ~250 
aptamer molecules per GNP to block its NanoZyme activity 
(see Supporting Information for details). The non-linear 
least square fitting of the aptamer-GNP interactions 
revealed a dissociation constant (Kd) of 1.85 × 10-8 M and a 
Hill coefficient (association stoichiometry) of 1.91. The Hill 
coefficient value of >1 reflects a positive cooperative 
binding behaviour, such that the binding of an aptamer 
molecule to the GNP surface enhances the affinity of other 
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aptamer molecules to bind to the surface of the NanoZyme 
(Table S2).66-67 The observed Kd for the aptamer-GNP 
interactions corroborates well with the previously 
observed values for stable non-covalently bonded 
biomolecule-GNP systems.68 The previous work has shown 

















































No. of virions / cells
R2 = 0.9987
Fig. 2. Sensor response for norovirus detection. (a) The colorimetric sensor response obtained from the incubation of 
the sensor probe for 10 min with increasing number of different biological entities including MNV, MS2 phage, S. aureus, and 
E. coli. The arrows represent the change in the intensity of blue colour formed as a result of aptamer dissociation from the 
GNP surface leading to the recovery of the NanoZyme activity. The red curve shows the linear fit of the sensor response in 
the presence of increasing number of norovirus. (b) The reaction velocity calculated from the sensor response using 
enzyme kinetic theory in the absence and presence of increasing number of norovirus. (c) In-batch, intra-batch and inter-
batch sensor reproducibility for three independent amounts of norovirus (20, 200 and 1,000 viruses) with corresponding 
precision and accuracy outlined in Table S3, Supporting Information.
picomolar range (10-12 M). Conversely, our current work 
shows the Kd for the AG3 aptamer to the GNPs is 1.85 × 10-8 
M. This suggests that the AG3 aptamer has almost four 
orders of magnitude higher binding affinity to MNV than to 
the GNP. This relative interaction strength of the AG3 
aptamer to MNV vs. GNP suggests that when the GNP-
aptamer conjugate is exposed to MNV (Step 3, Scheme 1), 
the aptamers will dissociate from the surface of the GNPs 
to bind effectively to the target norovirus (Step 4, Scheme 
1). Furthermore, the GNP-aptamer nanoconjugates remain 
stable in solution post-aptamer functionalisation (Fig. S5, 
Supporting Information), and serve as sensor probes for 
subsequent colorimetric detection of norovirus. 
The utility of these NanoZyme aptasensor probes for rapid, 
sensitive and selective detection of norovirus was assessed 
by first incubating the sensor probe independently with 
increasing population of different viruses and bacteria for 
10 min. We selected three different biological backgrounds 
in addition to norovirus, each representing a specific group 
of microorganisms that may be present as cross-
contaminants in the analyte sample containing norovirus. 
Among these, MNV serves as the target of interest, MS2 
phage represents a non-target virus with morphological 
and surface characteristics resembling noroviruses, 
Staphylococcus aureus represents Gram-positive group of 
bacteria and Escherichia coli represents Gram-negative 
bacteria (cell preparation outlined in Supporting 
Information). Fig. 2a shows the colorimetric response 
corresponding to each biological background obtained 
from the sensor probe in 10 min. It is clear that the 
NanoZyme activity is recovered specifically in the presence 
of norovirus, while all other microorganisms including 
structurally similar MS2 phage show only basal level 
activity. This highly specific response is attributed to the 
high affinity of AG3 aptamers that were specifically raised 
against the MNV surface. Furthermore, the sensor 
response (i.e., the intensity of blue colour) increases with 
the corresponding increase in the number of MNVs, 
supporting the viability of the proposed approach for 
norovirus sensing. As such, this norovirus NanoZyme 
aptasensor shows an outstanding sensitivity along with an 
impressive linear operating dynamic range of 20-1,000 
norovirus detection with high reliability (R2 = 0.9987) and 
that too within an assay time of just 10 min. 
To understand the underlying factors for this 
ultrasensitive response, we further calculated the absolute 
velocity of the sensor probe-induced reaction in the 
absence and presence of MNVs at the sensing time-point (t 
= 10 min). Fig. 2b and Fig. S6 shows that the absolute 
velocity of the reaction increases linearly with increasing 
MNV concentration. Remarkably, a 63% increase in the 
velocity is observed in the presence of as low as 20 MNVs, 
while 1000 MNVs enhances the TMB oxidation rate by 10.8 
times. The calculated limit of detection (LoD) for this assay 
is 3 MNV, which will correspond to 37% higher reaction 
velocity relative to that of the sensor probe (based on the 
regression analysis in Fig. S6). While the current study 
shows that we can reliably detect 20 MNV experimentally; 
it is also likely that we can experimentally detect the LoD 
of 3 MNV through employing robotic systems that can 
circumvent potential human sampling errors. 
Furthermore, considering that our assay employs 100 µL 
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of the original viral sample in a total assay volume of 200 
µL, we have experimentally shown that the current 
NanoZyme aptasensor can reliably detect at least 200 
MNV/mL of the original sample. Considering the LoD of 3 
MNV per assay, it should therefore be possible to detect a 
norovirus concentration of 30 MNV/mL in the original 
sample. This sensitivity is 
Table 1. Comparison of norovirus detection parameters among various platforms with emphasis on potential viral load 
(concentrations per mL) present in test analyte.
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(a)Linear dynamic range of the NanoZyme aptasensor is tunable by changing the sensor probe composition; (b)calculation for 
conversion of protein concentration to virus like particle (VLP) concentration is provided in Supporting Information. 
within the estimated median ID50 of NoV (18-1,015 viral 
genome copies).3 
Another desirable feature in a sensor is the ability to 
operate across a large range of target concentrations. 
However, this remains challenging as beyond a certain 
target concentration, the sensor response starts to 
saturate, underestimating the target concentration. We 
also noticed this limitation in our NanoZyme aptasensor, 
such that beyond 1,000 MNVs in the assay, the sensor 
response became non-linear with respect to the number of 
virions. To overcome 
this issue, we investigated the possibility of active 
modulation of the dynamic operational range of the 
norovirus NanoZyme aptasensor by changing the 
concentration of the NanoZyme (GNPs) in our sensor 
probe. When the concentration of GNPs during GNP-
aptamer sensor probe fabrication was changed from 75 µM 
originally to 100 µM and 150 µM; the linear dynamic range 
of operation could be actively modulated from 20-1,000 
MNV originally to 132-1,980 and 330-3,300 MNV, 
respectively (Fig. S7, Supporting Information). While the 
norovirus sensors with low detection limits are more 
desirable, the ability of the NanoZyme sensor to operate in 
different dynamic ranges will offer design flexibility for 
future in-field applications.
We further assessed the precision and accuracy of the 
norovirus sensor operating in the linear dynamic range of 
20-1,000 MNV under different conditions at the viral loads 
of 20, 200 and 1,000 MNV per assay (Fig. 2c). The first test 
involved performing 20 repeat experiments using sensor 
probes prepared in a single batch (in-batch). Subsequently, 
intra-batch variations (i.e. creating the sensor probe on 
different days using the GNPs prepared in a single batch) 
and inter-batch variations (i.e. creating the sensor probe 
using two independently synthesized GNPs) in norovirus 
sensor response were assessed. In each of these cases, the 
sensor responded with >95% (95.9-99.3%) precision, 
>95% (95-100%) accuracy at a significance level of 0.05, 
Page 5 of 10






























































Fig. 3. Performance of the NanoZyme aptasensor in 
complex matrices mimicking the real-world scenario. 
Sensor response obtained for three independent amounts of 
norovirus (20, 200 and 1,000) as well as in the absence of 
norovirus in the presence of a higher population (100,000 
cells) of non-specific targets (MS2 phage, S. aureus, and E. 
coli); in human serum; and in the shellfish (mussel) 
homogenate.
and 100% accuracy at a significance level of 0.1 (see Table 
S3, Supporting Information). These observations support 
the robustness of the NanoZyme aptasensor. The 
unprecedented sensitivity of the current norovirus sensing 
platform over previously reported norovirus sensors is 
summarised in Table 1. To allow a valid comparison 
between different norovirus sensors, the sensor 
performance data presented in Table 1 has been 
normalised to virus per mL of the original sample 
containing norovirus. The most sensitive norovirus 
detection system reported to date is based on an 
electrochemical aptasensor that offers a linear dynamic 
range of 360-2,170 MNV (equivalent of 12,000-72,333 
MNV/mL) with a LoD of 6,000 MNV/mL.2 In comparison, 
our current sensor shows 200 times higher sensitivity with 
an absolute LoD of ~3 viruses (30 MNV/mL) along with a 
tunable linear dynamic detection range that allows 
detection of 20-3,300 norovirus during the assay, 
facilitating the viral loads of 200-33,000 norovirus/mL 
detectable in test analyte. This outlines the outstanding 
sensitivity and robustness of the current NanoZyme 
aptasensor technology to selectively detect norovirus. In 
addition, the simplicity of the current assay and 
eliminating the need for trained technical personnel can 
potentially offer a viable option to develop point-of-care 
norovirus detection devices. 
We further evaluated the target-specific performance of 
the norovirus NanoZyme aptasensor in conditions similar 
to those encountered during the real-world analysis of a 
potentially contaminated sample (Fig. 3 and Table S3). 
These included three different scenarios, the first 
mimicking a situation where non-specific bacterial and 
viral loads might be significantly higher (105) than 
norovirus (20, 200 and 1000); the second case considering 
the potential interference caused by exogenous proteins 
(human sera); and the third scenario testing the ability of 
norovirus detection in raw shellfish (mussels) 
homogenate. The contaminant species present in these 
scenarios may potentially lead to non-specific response 
due to sample matrix interference. However, the 
robustness of the NanoZyme aptasensor supported by the 
high affinity of AG3 aptamer towards MNV resulted in 
excellent recoveries ranging between 96.7-101.8% during 
norovirus detection in each of these cases, as determined 
using the linear fit model obtained from Fig. 2b (Table 2). 
This demonstrates the outstanding ability of the current 
NanoZyme aptasensor technology to selectively detect 
norovirus even in the presence of other viral and bacterial 
contaminants, as well as in complex biological matrices.
In summary, we have demonstrated a highly robust 
NanoZyme aptasensor technology for rapid, highly 
selective and ultrasensitive colorimetric detection of MNV, 
a cultivable surrogate of human NoV. The proposed 
sensing technology combines the outstanding affinity of 
specific aptamers with the inherent peroxidase-like 
NanoZyme activity of GNPs to develop a robust platform 
for norovirus sensing with potential for further point-of-
care human diagnostic and in-field food and environmental 
screening development. This novel technology is the most 
sensitive norovirus sensor reported to date, which for the 
first time, demonstrates the ability to detect virus 
corresponding to a 
Table 2. The norovirus recovery obtained from the 
NanoZyme aptasensor in the presence of different 
contaminants.


















(a)100% recovery corresponds to expected norovirus 
numbers, whereas shifts towards lower/ higher values 
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represent relative under-estimation/ over-estimation of viral 
loads during norovirus quantification.
low infective dose. The potential of this colorimetric 
technology in eliminating the need for expensive 
instrumentation and trained specialized technical 




The Supporting Information is available free of charge on the 
ACS Publications website. 
Details of chemicals, experiments, instruments, materials 





The manuscript was written through contributions of all 
authors. ‡These authors contributed equally. 
ACKNOWLEDGMENT 
This work was supported through an Australian Research 
Council (ARC) Future Fellowship to V. Bansal (FT140101285). 
V. Bansal and R. Ramanathan acknowledge the ARC for 
funding support through the ARC Discovery scheme 
(DP170103477). R. Ramanathan acknowledges RMIT 
University for the Vice Chancellor Fellowship. B. K. Behera 
thanks the Commonwealth of Australia for an Endeavour 
Research Fellowship. The authors acknowledge the generous 
support of the Ian Potter Foundation for establishing Sir Ian 
Potter NanoBioSensing Facility at RMIT University. The 
authors also acknowledge the support from the RMIT 
Microscopy and Microanalysis Facility (RMMF) for technical 
assistance and providing access to characterization facilities. 
Support from the Australian Seafood CRC and Fisheries 
Research and Development Corporation are also 
acknowledged (FRDC 2011/726).
REFERENCES
1. Patel, M. M.; Hall, A. J.; Vinjé, J.; Parashar, U. D., Noroviruses: 
a comprehensive review. J. Clin. Virol. 2009, 44, 1-8.
2. Giamberardino, A.; Labib, M.; Hassan, E. M.; Tetro, J. A.; 
Springthorpe, S.; Sattar, S. A.; Berezovski, M. V.; DeRosa, M. C., 
Ultrasensitive norovirus detection using DNA aptasensor 
technology. PLoS One. 2013, e79087.
3. Teunis, P. F. M.; Moe, C. L.; Liu, P.; E. Miller, S.; Lindesmith, 
L.; Baric, R. S.; Le Pendu, J.; Calderon, R. L., Norwalk virus: How 
infectious is it? J. Med. Virol. 2008, 80, 1468-1476.
4. Lopman, B.; Atmar, R.; Baric, R.; Estes, M.; Hall, A.; Iturriza-
Gómara, M.; Kang, C.; Lee, B.; Parashar, U.; Riddle, M.; Vinjé, J. 
Global burden of norovirus and prospects for vaccine development; 
Global burden of norovirus and prospects for vaccine 
development, CDC Foundation Global Burden Report: 2015; pp 1-
44.
5. Lopman, B. A.; Steele, D.; Kirkwood, C. D.; Parashar, U. D., 
The vast and varied global burden of norovirus: prospects for 
prevention and control. PLoS Med. 2016, 13, e1001999.
6. Debbink, K.; Lindesmith, L. C.; Donaldson, E. F.; Baric, R. S., 
Norovirus immunity and the great escape. PLoS Pathog. 2012, 8, 
e1002921.
7. Ahmed, S. R.; Takemeura, K.; Li, T.-C.; Kitamoto, N.; Tanaka, 
T.; Suzuki, T.; Park, E. Y., Size-controlled preparation of 
peroxidase-like graphene-gold nanoparticle hybrids for the 
visible detection of norovirus-like particles. Biosens. Bioelectron. 
2016, 87, 558-565.
8. Hagström, A. E.; Garvey, G.; Paterson, A. S.; Dhamane, S.; 
Adhikari, M.; Estes, M. K.; Strych, U.; Kourentzi, K.; Atmar, R. L.; 
Willson, R. C., Sensitive detection of norovirus using phage 
nanoparticle reporters in lateral-flow assay. PLoS One 2015.
9. Gould, L. H.; Kline, J.; Monahan, C.; Vierk, K., Outbreaks of 
disease associated with food imported into the United States, 
1996–2014. Emerg. Infect. Dis. 2017, 23, 525-528.
10. Holley, R. A., Food safety challenges within North American 
free trade agreement (NAFTA) partners. Compr. Rev. Food Sci. 
Food Saf. 2011, 10, 131-142.
11. Kim, J.-H.; Park, J.-E.; Lin, M.; Kim, S.; Kim, G.-H.; Park, S.; Ko, 
G.; Nam, J.-M., Sensitive, Quantitative Naked-Eye Biodetection 
with Polyhedral Cu Nanoshells. Adv. Mater. 2017, 29, 1702945-
n/a.
12. Karim, M. N.; Anderson, S. R.; Singh, S.; Ramanathan, R.; 
Bansal, V., Nanostructured silver fabric as a free-standing 
NanoZyme for colorimetric detection of glucose in urine. Biosens. 
Bioelectron. 2018, 110, 8-15.
13. Daniel, M. C.; Astruc, D., Gold nanoparticles: assembly, 
supramolecular chemistry, quantum-size-related properties, and 
applications toward biology, catalysis, and nanotechnology. Chem. 
Rev. 2004, 104, 293-346.
14. Saha, K.; Agasti, S. S.; Kim, C.; Li, X.; Rotello, V. M., Gold 
nanoparticles in chemical and biological sensing. Chem. Rev. 
2012, 112, 2739-2779.
15. Miranda, O. R.; Creran, B.; Rotello, V. M., Array-based 
sensing with nanoparticles: “Chemical noses” for sensing 
biomolecules and cell surfaces. Curr. Opin. Chem. Biol. 2010, 14, 
728-736.
16. Sharma, T. K.; Ramanathan, R.; Rakwal, R.; Agrawal, G. K.; 
Bansal, V., Moving forward in plant food safety and security 
through NanoBioSensors: Adopt or adapt biomedical 
technologies? Proteomics 2015, 15, 1680-1692.
17. Walia, S.; Sabri, Y.; Ahmed, T.; Field, M. R.; Ramanathan, R.; 
Arash, A.; Bhargava, S. K.; Sriram, S.; Bhaskaran, M.; Bansal, V., 
Defining the role of humidity in the ambient degradation of few-
layer black phosphorus. 2D Mater. 2016, 4, 015025.
18. Ramanathan, R.; Walia, S.; Kandjani, A. E.; Balendran, S.; 
Mohammadtaheri, M.; Bhargava, S. K.; Kalantar-zadeh, K.; Bansal, 
V., Low-temperature fabrication of alkali metal–organic charge 
transfer complexes on cotton textile for optoelectronics and gas 
sensing. Langmuir 2015, 31, 1581-1587.
19. Ramanathan, R.; Kandjani, A. E.; Walia, S.; Balendhran, S.; 
Bhargava, S. K.; Kalantar-zadeh, K.; Bansal, V., 3-D nanorod arrays 
of metal-organic KTCNQ semiconductor on textiles for flexible 
organic electronics. RSC Adv. 2013, 3, 17654-17658.
20. De La Rica, R.; Stevens, M. M., Plasmonic ELISA for the 
ultrasensitive detection of disease biomarkers with the naked eye. 
Nature Nanotech. 2012, 7, 821.
21. Rodríguez-Lorenzo, L.; De La Rica, R.; Álvarez-Puebla, R. A.; 
Liz-Marzán, L. M.; Stevens, M. M., Plasmonic nanosensors with 
inverse sensitivity by means of enzyme-guided crystal growth. 
Nat. Mater. 2012, 11, 604.
22. Le, N. D. B.; Yesilbag Tonga, G.; Mout, R.; Kim, S.-T.; Wille, M. 
E.; Rana, S.; Dunphy, K. A.; Jerry, D. J.; Yazdani, M.; Ramanathan, R.; 
Rotello, C. M.; Rotello, V. M., Cancer Cell Discrimination Using 
Host–Guest “Doubled” Arrays. J. Am. Chem. Soc. 2017, 139, 8008-
8012.
Page 7 of 10






























































23. Rezk, A. R.; Walia, S.; Ramanathan, R.; Nili, H.; Ou, J. Z.; 
Bansal, V.; Friend, J. R.; Bhaskaran, M.; Yeo, L. Y.; Sriram, S., 
Acoustic–Excitonic Coupling for Dynamic Photoluminescence 
Manipulation of Quasi‐2D MoS2 Nanoflakes. Adv. Optical Mater. 
2015, 3, 888-894.
24. Behera, B. K.; Das, A.; Sarkar, D. J.; Weerathunge, P.; Parida, 
P. K.; Das, B. K.; Thavamani, P.; Ramanathan, R.; Bansal, V., 
Polycyclic Aromatic Hydrocarbons (PAHs) in inland aquatic 
ecosystems: Perils and remedies through biosensors and 
bioremediation. Environ. Poll. 2018, 241, 212-233.
25. Zou, W.; González, A.; Jampaiah, D.; Ramanathan, R.; Taha, 
M.; Walia, S.; Sriram, S.; Bhaskaran, M.; Dominguez-Vera, J. M.; 
Bansal, V., Skin color-specific and spectrally-selective naked-eye 
dosimetry of UVA, B and C radiations. Nat. Commun. 2018, 9, 
3743.
26. Selvakannan, P.; Ramanathan, R.; Plowman, B. J.; Sabri, Y. M.; 
Daima, H. K.; O'Mullane, A. P.; Bansal, V.; Bhargava, S. K., Probing 
the effect of charge transfer enhancement in off resonance mode 
SERS via conjugation of the probe dye between silver 
nanoparticles and metal substrates. Phys. Chem. Chem. Phys. 2013, 
15, 12920-12929.
27. Chen, F.; Tang, F.; Yang, C.-T.; Zhao, X.; Wang, J.; Thierry, B.; 
Bansal, V.; Dai, J.; Zhou, X., Fast and Highly Sensitive Detection of 
Pathogens Wreathed with Magnetic Nanoparticles Using Dark-
Field Microscopy. ACS Sens. 2018, DOI: 
10.1021/acssensors.8b00785.
28. Muhamadali, H.; Subaihi, A.; Mohammadtaheri, M.; Xu, Y.; 
Ellis, D. I.; Ramanathan, R.; Bansal, V.; Goodacre, R., Rapid, 
accurate, and comparative differentiation of clinically and 
industrially relevant microorganisms via multiple vibrational 
spectroscopic fingerprinting. Analyst 2016, 141, 5127-5136.
29. Boisselier, E.; Astruc, D., Gold nanoparticles in 
nanomedicine: preparations, imaging, diagnostics, therapies and 
toxicity. Chem. Soc. Rev. 2009, 38, 1759-1782.
30. Zohora, N.; Kumar, D.; Yazdani, M.; Rotello, V. M.; 
Ramanathan, R.; Bansal, V., Rapid colorimetric detection of 
mercury using biosynthesized gold nanoparticles. Colloid Surf. A. 
2017, 532, 451-457.
31. Zayats, M.; Baron, R.; Popov, I.; Willner, I., Biocatalytic 
growth of Au nanoparticles: from mechanistic aspects to 
biosensors design. Nano Lett. 2005, 5, 21-25.
32. Carnovale, C.; Bryant, G.; Shukla, R.; Bansal, V., Size, shape 
and surface chemistry of nano-gold dictate its cellular 
interactions, uptake and toxicity. Prog. Mater Sci. 2016, 83, 152-
190.
33. Sabri, Y. M.; Ippolito, S. J.; Tardio, J.; Bansal, V.; O’Mullane, A. 
P.; Bhargava, S. K., Gold nanospikes based microsensor as a highly 
accurate mercury emission monitoring system. Sci. Rep. 2014, 4, 
6741.
34. Kim, J. E.; Choi, J. H.; Colas, M.; Kim, D. H.; Lee, H., Gold-based 
hybrid nanomaterials for biosensing and molecular diagnostic 
applications. Biosens. Bioelectron. 2016, 80, 543-559.
35. Mohammadzadeh-Asl, S.; Keshtkar, A.; Ezzati Nazhad 
Dolatabadi, J.; de la Guardia, M., Nanomaterials and phase 
sensitive based signal enhancment in surface plasmon resonance. 
Biosens. Bioelectron. 2018, 110, 118-131.
36. Syedmoradi, L.; Daneshpour, M.; Alvandipour, M.; Gomez, F. 
A.; Hajghassem, H.; Omidfar, K., Point of care testing: The impact 
of nanotechnology. Biosens. Bioelectron. 2017, 87, 373-387.
37. Reguera, J.; Langer, J.; Jiménez De Aberasturi, D.; Liz-
Marzán, L. M., Anisotropic metal nanoparticles for surface 
enhanced Raman scattering. Chem. Soc. Rev. 2017, 46, 3866-3885.
38. Anderson, S. R.; Mohammadtaheri, M.; Kumar, D.; O'Mullane, 
A. P.; Field, M. R.; Ramanathan, R.; Bansal, V., Robust 
nanostructured silver and copper fabrics with localized surface 
plasmon resonance property for effective visible light induced 
reductive catalysis. Adv. Mater. Interfaces 2016, 3, 1500632.
39. Vilela, D.; González, M. C.; Escarpa, A., Sensing colorimetric 
approaches based on gold and silver nanoparticles aggregation: 
chemical creativity behind the assay. A review. Anal. Chim. Acta 
2012, 751, 24-43.
40. Jv, Y.; Li, B.; Cao, R., Positively-charged gold nanoparticles as 
peroxidiase mimic and their application in hydrogen peroxide and 
glucose detection. Chem. Commun. 2010, 46, 8017-8019.
41. Long, Y. J.; Li, Y. F.; Liu, Y.; Zheng, J. J.; Tang, J.; Huang, C. Z., 
Visual observation of the mercury-stimulated peroxidase mimetic 
activity of gold nanoparticles. Chem. Commun. 2011, 47, 11939-
11941.
42. Guo, L.; Xu, Y.; Ferhan, A. R.; Chen, G.; Kim, D.-H., Oriented 
gold nanoparticle aggregation for colorimetric sensors with 
surprisingly high analytical figures of merit. J. Am. Chem. Soc. 
2013, 135, 12338-12345.
43. Lin, Y.; Ren, J.; Qu, X., Catalytically active nanomaterials: a 
promising candidate for artificial enzymes. Acc. Chem. Res. 2014, 
47, 1097-1105.
44. Weerathunge, P.; Sharma, T. K.; Ramanathan, R.; Bansal, V., 
Nanozyme-Based Environmental Monitoring. In Advanced 
Environmental Analysis: Applications of Nanomaterials, The Royal 
Society of Chemistry: 2017; Vol. 2, pp 108-132.
45. Wei, H.; Wang, E., Nanomaterials with enzyme-like 
characteristics (nanozymes): next-generation artificial enzymes. 
Chem. Soc. Rev. 2013, 42, 6060-6093.
46. Wang, X.; Hu, Y.; Wei, H., Nanozymes in bionanotechnology: 
from sensing to therapeutics and beyond. Inorg. Chem. Front. 
2016, 3, 41-60.
47. Tonga, G. Y.; Jeong, Y.; Duncan, B.; Mizuhara, T.; Mout, R.; 
Das, R.; Kim, S. T.; Yeh, Y.-C.; Yan, B.; Hou, S.; Rotello, V. M., 
Supramolecular regulation of bioorthogonal catalysis in cells 
using nanoparticle-embedded transition metal catalysts. Nat. 
Chem. 2015, 7, 597-603.
48. de la Rica, R.; Stevens, M. M., Plasmonic ELISA for the 
ultrasensitive detection of disease biomarkers with the naked eye. 
Nat. Nanotech. 2012, 7, 821-824.
49. Weerathunge, P.; Ramanathan, R.; Shukla, R.; Sharma, T. K.; 
Bansal, V., Aptamer-controlled reversible inhibition of gold 
nanozyme activity for pesticide sensing. Anal. Chem. 2014, 86, 
11937-11941.
50. Sharma, T. K.; Ramanathan, R.; Weerathunge, P.; 
Mohammadtaheri, M.; Daima, H. K.; Shukla, R.; Bansal, V., 
Aptamer-mediated 'turn-off/turn-on' nanozyme activity of gold 
nanoparticles for kanamycin detection. Chem. Commun. 2014, 50, 
15856-15859.
51. Byrne, B.; Stack, E.; Gilmartin, N.; O’Kennedy, R., Antibody-
based sensors: Principles, problems and potential for detection of 
pathogens and associated toxins. Sensors 2009, 9, 4407-4445.
52. Kovárová, M.; Dráber, P., New specificity and yield enhancer 
of polymerase chain reactions. Nucleic Acids Res. 2000, 28, e70-
e70.
53. Zhao, J.; Patwa, T. H.; Qiu, W.; Shedden, K.; Hinderer, R.; 
Misek, D. E.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M., 
Glycoprotein Microarrays with Multi-Lectin Detection:  Unique 
Lectin Binding Patterns as a Tool for Classifying Normal, Chronic 
Pancreatitis and Pancreatic Cancer Sera. J. Proteome Res. 2007, 6, 
1864-1874.
54. Dhiman, A.; Kalra, P.; Bansal, V.; Bruno, J. G.; Sharma, T. K., 
Aptamer-based point-of-care diagnostic platforms. Sens. Actuators 
B. 2017, 246, 535-553.
55. Keefe, A. D.; Pai, S.; Ellington, A., Aptamers as therapeutics. 
Nat. Rev. Drug Discov. 2010, 9, 537-550.
56. Hung, L.-Y.; Wang, C.-H.; Che, Y.-J.; Fu, C.-Y.; Chang, H.-Y.; 
Wang, K.; Lee, G.-B., Screening of aptamers specific to colorectal 
cancer cells and stem cells by utilizing On-chip Cell-SELEX. Sci. 
Rep. 2015, 5.
57. Wu, X.; Chen, J.; Wu, M.; Zhao, J. X., Aptamers: active 
targeting ligands for cancer diagnosis and therapy. Theranostics 
2015, 5, 322.
58. Chang, Y.-C.; Yang, C.-Y.; Sun, R.-L.; Cheng, Y.-F.; Kao, W.-C.; 
Yang, P.-C., Rapid single cell detection of Staphylococcus aureus 
Page 8 of 10






























































by aptamer-conjugated gold nanoparticles. Sci. Rep. 2013, 3, 
1863.
59. Yang, M.; Peng, Z.; Ning, Y.; Chen, Y.; Zhou, Q.; Deng, L., 
Highly specific and cost-efficient detection of Salmonella 
Paratyphi A combining aptamers with single-walled carbon 
nanotubes. Sensors 2013, 13, 6865-6881.
60. Park, J.-W.; Lee, S. J.; Choi, E.-J.; Kim, J.; Song, J.-Y.; Gu, M. B., 
An ultra-sensitive detection of a whole virus using dual aptamers 
developed by immobilization-free screening. Biosens. Bioelectron. 
2014, 51, 324-329.
61. Ruscito, A.; DeRosa, M. C., Small-Molecule Binding 
Aptamers: Selection Strategies, Characterization, and 
Applications. Front. Chem. 2016, 4.
62. Ettayebi, K.; Crawford, S. E.; Murakami, K.; Broughman, J. R.; 
Karandikar, U.; Tenge, V. R.; Neill, F. H.; Blutt, S. E.; Zeng, X.-L.; Qu, 
L.; Kou, B.; Opekun, A. R.; Burrin, D.; Graham, D. Y.; Ramani, S.; 
Atmar, R. L.; Estes, M. K., Replication of human noroviruses in 
stem cell–derived human enteroids. Science 2016, 353, 1387-
1393.
63. Singh, M.; Weerathunge, P.; Liyanage, P. D.; Mayes, E.; 
Ramanathan, R.; Bansal, V., Competitive Inhibition of the Enzyme-
Mimic Activity of Gd-Based Nanorods toward Highly Specific 
Colorimetric Sensing of l-Cysteine. Langmuir 2017, 33, 10006-
10015.
64. Karim, M. N.; Singh, M.; Weerathunge, P.; Bian, P.; Zheng, R.; 
Dekiwadia, C.; Ahmed, T.; Walia, S.; Della Gaspera, E.; Singh, S.; 
Ramanathan, R.; Bansal, V., Visible-Light-Triggered Reactive-
Oxygen-Species-Mediated Antibacterial Activity of Peroxidase-
Mimic CuO Nanorods. ACS Appl. Nano Mater. 2018, 1, 1694-1704.
65. Li, H.; Rothberg, L., Colorimetric detection of DNA sequences 
based on electrostatic interactions with unmodified gold 
nanoparticles. Proc. Natl. Acad. Sci. USA 2004, 101, 14036-14039.
66. Hulme, E. C.; Trevethick, M. A., Ligand binding assays at 
equilibrium: validation and interpretation. Brit. J. Pharmacol. 
2010, 161, 1219-1237.
67. Dahan, D. S.; Dibas, M. I.; Petersson, E. J.; Auyeung, V. C.; 
Chanda, B.; Bezanilla, F.; Dougherty, D. A.; Lester, H. A., A 
fluorophore attached to nicotinic acetylcholine receptor βM2 
detects productive binding of agonist to the αδ site. Proc. Natl. 
Acad. Sci. USA 2004, 101, 10195-10200.
68. Rana, S.; Le, N. D. B.; Mout, R.; Saha, K.; Gulen, Y. T.; Bain, R. 
E. S.; Miranda, O. R.; Rotello, C. M.; Rotello, V. M., A multichannel 
nanosensor for instantaneous readout of cancer drug 
mechanisms. Nat. Nanotech. 2014, 10, 65-69.
69. Han, K. N.; Choi, J.-S.; Kwon, J., Three-dimensional paper-
based slip device for one-step point-of-care testing. Sci. Rep. 
2016, 6, 25710.
Page 9 of 10
































































Page 10 of 10
ACS Paragon Plus Environment
Analytical Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
